Central Pacific Bank Trust Division Invests $3.58 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Central Pacific Bank Trust Division acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,302 shares of the healthcare conglomerate’s stock, valued at approximately $3,576,000.

Several other institutional investors also recently modified their holdings of UNH. Bell Investment Advisors Inc raised its position in UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the last quarter. Harbor Investment Advisory LLC raised its position in UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the last quarter. Verdence Capital Advisors LLC raised its position in UnitedHealth Group by 2.1% in the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after purchasing an additional 342 shares during the last quarter. Austin Private Wealth LLC raised its position in shares of UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares during the last quarter. Finally, Bellecapital International Ltd. raised its position in shares of UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.6 %

NYSE UNH traded up $2.78 during trading hours on Tuesday, hitting $492.12. 3,056,843 shares of the company traded hands, compared to its average volume of 4,255,447. The business’s 50-day moving average is $498.47 and its 200-day moving average is $500.21. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $452.94 billion, a price-to-earnings ratio of 30.23, a P/E/G ratio of 1.44 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the prior year, the firm posted $6.26 earnings per share. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.71%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Morgan Stanley dropped their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Piper Sandler upped their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Tuesday. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, June 28th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.